Preclinical efficacy and clinical translatability of resmetirom in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

被引：0

作者：

Feigh, Michael ^{[1
]}

Nohr-Meldgaard, Jacob ^{[1
]}

Pors, Susanne ^{[1
]}

Hansen, Henrik B. ^{[1
]}

机构：

[1] Gubra, Horsholm, Denmark

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

WED-543

引用

页码：S800 / S800

页数：1

共 50 条

[1] Clinical translatability of the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
Feigh, Michael
Andersen, Maja
Eskesen, Nicolas
Oro, Denise
Hansen, Henrik B.
JOURNAL OF HEPATOLOGY, 2024, 80 : S568 - S568
[2] CLINICAL TRANSLATABILITY OF THE GAN DIET-INDUCED OBESE AND BIOPSY-CONFIRMED MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
Feigh, Michael
Andersen, Maja W.
Madsen, Martin R.
Oro, Denise
Hansen, Henrik H.
HEPATOLOGY, 2022, 76 : S736 - S737
[3] Synergistic hepatoprotective effects of semaglutide and resmetirom combination therapy in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
Voldum-Clausen, Kristoffer
Norlin, Jenny Egecioglu
Veidal, Sanne Skovgard
Oro, Denise
Nilsson, Line
Hansen, Henrik B.
Feigh, Michael
JOURNAL OF HEPATOLOGY, 2024, 80 : S580 - S580
[4] Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
Mollerhoj, Mathias B.
Veidal, Sanne S.
Thrane, Kirstine Tolbol
Oro, Denise
Overgaard, Agnete
Salinas, Casper Gravesen
Madsen, Martin Ronn
Pfisterer, Larissa
Vyberg, Mogens
Simon, Eric
Broermann, Andre
Vrang, Niels
Jelsing, Jacob
Feigh, Michael
Hansen, Henrik H.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (05): : 1167 - 1186
[5] Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
Kristiansen, Maria Nicoline Baandrup
Veidal, Sanne Skovgard
Christoffersen, Christina
Feigh, Michael
Vrang, Niels
Roth, Jonathan David
Erickson, Mary
Adorini, Luciano
Jelsing, Jacob
BMC GASTROENTEROLOGY, 2019, 19 (01)
[6] Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
Maria Nicoline Baandrup Kristiansen
Sanne Skovgård Veidal
Christina Christoffersen
Michael Feigh
Niels Vrang
Jonathan David Roth
Mary Erickson
Luciano Adorini
Jacob Jelsing
BMC Gastroenterology, 19
[7] HEPATOPROTECTIVE EFFECTS OF SEMAGLUTIDE IN THE GAN DIET-INDUCED OBESE AND BIOPSY-CONFIRMED MOUSE MODEL OF NASH WITH ADVANCED FIBROSIS AND HEPATOCELLULAR CARCINOMA
Nielsen, Malte Hasle
Mollerhoj, Mathias Bonde
Oro, Denise
Madsen, Martin R.
Vyberg, Mogens
Hansen, Henrik H.
Feigh, Michael
HEPATOLOGY, 2022, 76 : S737 - S738
[8] HEPATOPROTECTIVE EFFECTS OF SEMAGLUTIDE IN THE GAN DIET-INDUCED OBESE AND BIOPSY-CONFIRMED MOUSE MODEL OF NASH WITH ADVANCED FIBROSIS AND HEPATOCELLULAR CARCINOMA
Heimburger, Sebastian Moller Nguyen
Nielsen, Malte H.
Mollerhoj, Mathias Bonde
Oro, Denise
Madsen, Martin R.
Vyberg, Mogens
Hansen, Henrik H.
Feigh, Michael
GASTROENTEROLOGY, 2023, 164 (06) : S1262 - S1262
[9] EVALUATION OF CLINICAL TRANSLATABILITY OF THE DIET-INDUCED OBESE AND BIOPSY-CONFIRMED GUBRA AMYLIN MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
Rigbolt, Kristoffer
Veidal, Sanne
Suppli, Malte
Eriksen, Peter Lykke
Feigh, Michael
Knop, Filip Krag
Gronbaek, Henning
Thomsen, Karen Louise
Jelsing, Jacob
Vrang, Niels
HEPATOLOGY, 2019, 70 : 1320A - 1321A
[10] Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
Mathias Flensted-Jensen
Denise Oró
Emma A. Rørbeck
Chen Zhang
Martin Rønn Madsen
Andreas Nygaard Madsen
Jenny Norlin
Michael Feigh
Steen Larsen
Henrik H. Hansen
BMC Gastroenterology, 24

← 1 2 3 4 5 →